featured
Standard Chemotherapy With or Without Bevacizumab in Newly Diagnosed Ovarian Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Standard Chemotherapy With or Without Bevacizumab for Women With Newly Diagnosed Ovarian Cancer (ICON7): Overall Survival Results of a Phase 3 Randomised Trial
Lancet Oncol 2015 Jun 23;[EPub Ahead of Print], AM Oza, AD Cook, J Pfisterer, A Embleton, JA Ledermann, E Pujade-Lauraine, G Kristensen, MS Carey, P Beale, A Cervantes, TW Park-Simon, G Rustin, F Joly, MR Mirza, M Plante, M Quinn, A Poveda, GC Jayson, D Stark, AM Swart, L Farrelly, R Kaplan, MK Parmar, TJ PerrenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.